Towards a Unified Framework for Protein Interaction Site Prediction Using Hierarchical Protein Representations

Authors

Nguyen, V. T. D., Johnstone, J. K., Hy, T.-S.

Abstract

Proteins interact with a wide range of biomolecular partners, yet identifying the interaction sites that mediate these events remains a major challenge for understanding cellular function and guiding drug discovery. Existing computational methods are typically designed for specific interaction classes and often rely on task-specific features. Here, we introduce PRIME-ISP, a structure-based framework for predicting interaction sites across diverse biomolecular interaction types using a unified architecture. PRIME-ISP represents proteins at five organizational levels, including solvent-excluded surfaces, atoms, residues, secondary-structure elements, and whole proteins, and integrates information across these scales through coupled bottom-up and top-down propagation. This hierarchical representation jointly captures local geometry and global structural context, enabling a single architecture to address chemically and geometrically distinct binding problems without task-specific modifications. We evaluate PRIME-ISP on protein, peptide, DNA, RNA, small-molecule, metal, and carbohydrate interaction-site prediction benchmarks. Across these tasks, PRIME-ISP consistently outperforms a recent unified sequence-based predictor and achieves performance comparable to specialized methods while requiring no interaction-specific features. These results demonstrate that hierarchical structural representations provide a flexible foundation for interaction-site prediction across diverse biomolecular interactions. Source code and data are publicly available at https://github.com/HySonLab/PRIME-ISP

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 23 Oct 2026.

Stats

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.